Skip to content

A prospective study of antithymocyte globulin in preventing graft versus host disease after HLA-identical sibling hematopoietic stem cell transplantation

A prospective study of antithymocyte globulin in preventing graft versus host disease after HLA-identical sibling hematopoietic stem cell transplantation

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035017
Enrollment
Unknown
Registered
2020-07-28
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic stem cell transplantation for hematological diseases

Interventions

single arm:antithymocyte globulin

Sponsors

Department of Hematology, the Third Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age: 14-55 years old; 2. Gender: male and female are not limited; 3. The diagnosis is hematologic diseases (including acute leukemia, chronic myeloid leukemia, myelodysplastic syndrome, etc.); 4. The ECOG score is 0-2; 5. HLA-identical Sibling allogeneic hematopoietic stem cell transplantation; 6. Normal cardiac function: ejection fraction >= 50%; 7. Serum bilirubin <= 35 µ mol / L , AST or ALT is less than 2 times of the upper limit of normal value; 8. Serum creatinine <= 130 µ mol / L; 9. The patient had signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe ATG allergy (such as anaphylactic shock or laryngeal edema); 2. Severe infection not under control before transplantation; 3. Haploid ,unrelated hematopoietic stem cell transplantation or non myeloablative conditioning of allogeneic hematopoietic stem cell transplantation;

Design outcomes

Primary

MeasureTime frame
Incidence of chronic graft versus host disease;

Secondary

MeasureTime frame
Incidence of acute graft versus host disease;Implantation rate;Incidence of infection;

Countries

China

Contacts

Public ContactYanling Sun

Department of Hematology, The Third Affiliated Hospital of Sun Yat-Sen University

delice2010@126.com?????,??http://www.medresman.org.cn?????????????????????(?????)?

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026